A 38-year-old male patient with a duodenal ulcer is treated successfully with the drug cimetidine. The basis for cimetidine's inhibition of gastric H+ secretion is that it
(A) blocks muscarinic receptors on parietal cells
(B) blocks H2 receptors on parietal cells
(C) increases intracellular cyclic adenosine monophosphate (CAMP) levels
(D) blocks H+,K+-adenosine triphosphatase (ATPase)
(E) enhances the action of acetylcholine (ACh) on parietal cells
The answer is B
Cimetidine is a reversible inhibitor of H2 receptors on parietal cells and blocks H+ secretion. Cyclic adenosine monophosphate (cAMP) (the second messenger for histamine) levels would be expected to decrease, not increase. Cimetidine also blocks the action of acetylcholine (ACh) to stimulate H+ secretion. Omeprazole blocks H+, K+-adenosine triphosphatase (ATPase) directly.
(A) blocks muscarinic receptors on parietal cells
(B) blocks H2 receptors on parietal cells
(C) increases intracellular cyclic adenosine monophosphate (CAMP) levels
(D) blocks H+,K+-adenosine triphosphatase (ATPase)
(E) enhances the action of acetylcholine (ACh) on parietal cells
The answer is B
Cimetidine is a reversible inhibitor of H2 receptors on parietal cells and blocks H+ secretion. Cyclic adenosine monophosphate (cAMP) (the second messenger for histamine) levels would be expected to decrease, not increase. Cimetidine also blocks the action of acetylcholine (ACh) to stimulate H+ secretion. Omeprazole blocks H+, K+-adenosine triphosphatase (ATPase) directly.